Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women

Sexually Transmitted Diseases

Volumn 38, Issue 10, 2011, Pages 902-906

  Sauvaget, Catherine ^a   Nene, Bhagwan M ^b   Jayant, Kasturi ^b   Kelkar, Rohini ^c   Malvi, Sylla G ^b   Shastri, Surendranath S ^c   Sankaranarayanan, Rengaswamy ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Nargis Dutt Memorial Cancer Hospital   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; EDUCATION; FEMALE; HIGH RISK POPULATION; HUMAN; INDIA; INDIAN; LIFESTYLE; MAJOR CLINICAL STUDY; MANUAL LABOR; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PREVALENCE; QUESTIONNAIRE; RURAL AREA; SEXUAL INTERCOURSE; SOCIOECONOMICS; UTERINE CERVIX CYTOLOGY; WIDOW;

ADULT; AGE FACTORS; FEMALE; HUMANS; INCIDENCE; INDIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REPRODUCTIVE HISTORY; RISK FACTORS; RURAL POPULATION; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 80052995589     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318223be5f     Document Type: Article

References (26)

1. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
2. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527. (Pubitemid 36159887)
3. Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: Critical role of duration of infection. J Natl Cancer Inst 2010; 102:315-324.
4. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(suppl 1):S1-S15.
5. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans: Human papillomaviruses. Lyon, France: IARC, 2007.
6. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.
7. Sankaranarayanan R, Nene BM, Dinshaw KA, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005; 116:617-623. (Pubitemid 41099199)
8. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360:1385-1394.
9. SAS Institute Inc. SAS/STAT User's Guide, Version 9.3.1. Cary, NC: SAS Institute Inc, 2002.
10. Rajkumar T, Franceschi S, Vaccarella S, et al. Role of paan chewing and dietary habits in cervical carcinoma in Chennai. India Br J Cancer 2003; 88:1388-1393. (Pubitemid 36606420)
11. Mehta SH, Gupta A, Sahay S, et al. High HIV prevalence among a high-risk subgroup of women attending sexually transmitted infection clinics in Pune, India. J Acquir Immune Defic Syndr 2006; 41:75-80. (Pubitemid 41786023)
12. Aggarwal R, Gupta S, Nijhawan R, et al. Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: A hospital based study from North India. Indian J Cancer 2006; 43:110-116. (Pubitemid 44701604)
13. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87:324-333.
14. Ronco G, Ghisetti V, Segnan N, et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005; 41:297-305. (Pubitemid 40126963)
15. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103:413-421. (Pubitemid 36076436)
16. Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: A populationbased study. Br J Cancer 2006; 95:96-101. (Pubitemid 43980561)
17. Dunne E, Unger E, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-819. (Pubitemid 46333946)
18. Franceschi S, Rajkumar R, Snijders PJ, et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92:601-606. (Pubitemid 40395546)
19. Gupta S, Sodhani P, Sharma A, et al. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: Risk factor analysis and implications for screening and prophylaxis. Cytopathology 2009; 20:249-255.
20. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 2004; 90:638-645. (Pubitemid 38297204)
21. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119:2677-2684. (Pubitemid 44691325)
22. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464-474. (Pubitemid 30182883)
23. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993; 20:279-285. (Pubitemid 23286958)
24. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91:412-420. (Pubitemid 32049638)
25. Munoz N, Kato I, Bosch FX, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 1996; 23:504-510. (Pubitemid 26391576)
26. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: Pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15:2148-2153. (Pubitemid 44877039)